BioDetection Systems (BDS) b.v.

BioDetection Systems (BDS) is specialized in developing and applying mechanism-based, ultrasensitive, biological monitoring to protect human health and the environment. As such BDS offers a range of unique products, including an extensive panel of high-throughput- CALUX reporter assays and complementary technologies. BDS’ innovative technologies can be used to rapidly evaluate major types of toxicity relevant for regulatory risk assessment, allowing assurance of consumer safety and -confidence. Quantitative measurements allow assessment of points-of -departure in chemical risk assessment, replacing animal experimentation. BDS provides these services through its own service laboratory, and under license by laboratories across the globe.